Phase hub

Phase IV clinical trial failures

Explore 2,858 stopped phase iv clinical trials with sponsors, indications, and stop-reason signals.

This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 85 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.

Total stopped trials2,858
Likely biological signals85
Shown below100

Dominant stop reasons

OPERATIONAL
1,663
OTHER/UNKNOWN
1,104
EFFICACY/FUTILITY
52
SAFETY
33
REGULATORY
6

Notable sponsors

Massachusetts General Hospital
45
Duke University
30
Northwestern University
30
Novartis Pharmaceuticals
30
University of California, San Francisco
30

Related phases

Phase IV
2,858

Crawlable stopped-trial records

Open Explore

Showing up to 100 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.

NCT04640636: IM Ketamine vs Midazolam for Suicidal ER Patients

Phase IV Depression, Unipolar trial by New York State Psychiatric Institute. Stop reason: OTHER/UNKNOWN.

The U.S. Department of Health and Human Services (HHS) Office of Human Research Protections (OHRP) issued an FWA restriction on NYSPI research that also included a pause of human subjects research as of June 23, 2023.

NCT03699293: NSAIDs vs. Coxibs in the Presence of Aspirin

Phase IV Rheumatoid Arthritis trial by Platelet and Thrombosis Research, LLC. Stop reason: OPERATIONAL.

Our group moved from Inova Heart and Vascular institute to Sinai Hospital with Platelet and Thrombosis, LLC taking over sponsorship. Study was then IRB approved at Sinai on March, 2020 but closed prior to any additional enrolment due to COVID.